Iqvia Holdings (IQV) Net Equity Issued and Repurchased (2012 - 2013)
Iqvia Holdings' (IQV) quarterly Net Equity Issued and Repurchased came in at $35.4 million in Q4 2013, up 1574.86% year-over-year from $2.1 million in Q4 2012, and up 9401.84% quarter-over-quarter from -$381000.0 in Q3 2013.
Analysis
Iqvia Holdings (IQV) Net Equity Issued and Repurchased (2012 - 2013) Analysis & Trends
Iqvia Holdings has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $35.4 million for Q4 2013.
- In Q4 2013, Net Equity Issued and Repurchased rose 1574.86% year-over-year to $35.4 million; the TTM figure through Dec 2013 stood at $525.0 million (changed N/A YoY), while the FY2019 annual figure was $11.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at $35.4 million for Q4 2013 at Iqvia Holdings, up from -$381000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $489.8 million in Q2 2013 to a low of -$381000.0 in Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 35.44 Mn |
| Sep 30, 2013 | -381,000.00 |
| Jun 30, 2013 | 489.79 Mn |
| Mar 31, 2013 | 149,000.00 |
| Dec 31, 2012 | 2.12 Mn |